Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Diabetes Mellitus, Type 2 1Colorectal Neoplasms 1

Interventions

Blood Specimen Collection 2voglibose 1saxagliptin 1repaglinide 1miglitol 1metahexamide 1meglitinide 1glymidine 1glisoxepide 1gliquidone 1glimepiride 1glibornuride 1Vildagliptin 1Urine Specimen Collection 1Troglitazone 1Tolbutamide 1Tolazamide 1Thiazolidinediones 1Surveys and Questionnaires 1Sulfonylurea Compounds 1Sitagliptin Phosphate 1Rosiglitazone 1Plant Proteins 1Pioglitazone 1Phenformin 1Nateglinide 1Metformin 1Liraglutide 1Hypoglycemic Agents 1Glycoside Hydrolase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diabetes Mellitus, Type 2 × Plant Proteins × Gastrointestinal × Clear all
NCT03206827 2021-09-27

ScenoProt

University of Helsinki

Phase NA Completed
147 enrolled
Gastrointestinal

Diabetes Mellitus, Type 2, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡